Sanofi Win Marks Another Step In Drugmakers' Twombly March

Law360, New York (August 2, 2012, 8:52 PM EDT) -- A Sanofi SA subsidiary and Bristol-Myers Squibb Co. on Tuesday won the dismissal of a suit in Ohio over injuries allegedly caused by the anti-clotting drug Plavix, successfully attacking the plaintiff's claims under Twombly and Iqbal — a tactic attorneys say drugmakers are employing more frequently in product liability suits.

U.S. District Judge Donald Nugent agreed with the companies' contention that plaintiff Lorenzo Tolliver's allegations didn’t meet the standard set by the U.S. Supreme Court's Twombly and Iqbal rulings. The pair of decisions, handed down in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Tolliver et al v. Bristol-Myers Squibb Company et al


Case Number

1:12-cv-00754

Court

Ohio Northern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Donald C. Nugent

Date Filed

March 27, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.